Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies

This study has been completed.
Sponsor:
Collaborators:
Pfizer
Information provided by:
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
NCT00246103
First received: October 28, 2005
Last updated: November 21, 2013
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2008
  Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)